Status:
COMPLETED
Antimicrobial Photodynamic Therapy in Chronic Periodontitis and Diabetes Mellitus
Lead Sponsor:
King Saud University
Conditions:
Type 2 Diabetes Mellitus
Prediabetic State
Eligibility:
All Genders
30-60 years
Phase:
PHASE2
PHASE3
Brief Summary
With this design, this study hypothesizes that; (i) ICG-PDT would produce superior clinical, microbiological, and immune-inflammatory outcomes as compared to RSD and (ii) ICG-PDT would produce equal e...
Eligibility Criteria
Inclusion
- aged ≥30 years
- clinically diagnosed with mild to moderate periodontitis
- self-reported type-2 DM for ≥2 years confirmed by a physician with HbA1c levels ≥6.5%
- patients who complied with the treatment protocol.
Exclusion
- (i) pregnancy and lactation (ii) who had taken antibiotics in the previous 3 months (iii) who had undergone periodontal therapy or any decontamination treatment in their oral cavity in the previous 6 months (iv) former/current smokers (v) failure to provide a signed informed consent.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04857346
Start Date
June 1 2020
End Date
February 1 2021
Last Update
April 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
College of Applied Medical Sciences, King Saud University
Riyadh, Saudi Arabia, 11454